Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIGHT: Low-dose Colchicine in Elderly Multivessel CAD
NCT06025071Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in coronary artery disease (CAD), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06025071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025071.